APx Acquisition Corp. I
Status: Live Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $172.50M |
|---|---|
| IPO Date | Dec 7, 2021 |
| CEO | Kyle P. Bransfield |
| Left Lead | BofA Securities |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 15 + 3 + 3 + 3 + 12 |
| IPO Sector |
General
Companies in a Spanish-speaking Latin American country (“SSLA”) or companies outside a SSLA that provide goods and services to Spanish speaking markets |
| IPO Geography | LatAm |
| Target Company | OmnigenicsAI Corp |
| Deal Announced | TBD |
| Deal Size, $M | $340.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Dec 4, 2024 |
APXI
APXIU
APXIW
| Price | $11.87 |
|---|---|
| Last closing price | $11.87 |
| H/L, today | $11.85 / $11.87 |
| H/L, 52-week | $9.86 / $11.04 |
| Volume, today | 11 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on APx Acquisition Corp. I:
- Structure and cap table
- 7 directors & officers
- 26 filings and events
- 1 underwriters
- 1 deal advisors
- 7 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Kyle P. Bransfield | 40 | CEO and Chairman |
| Xavier Martinez | 32 | CFO |
| Alfredo Vara Alonso | 55 | Director |
| Daniel Braatz | 40 | Director |
| Daniel Mudd | 65 | Director |
| Fara Remtulla | 51 | Director |
| Thomas P.M. Barry | 41 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| BofA Securities | BR | 15,000,000 | units |
| 15,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.